MAGic BioProcessing receives SEK 1.75 million from Vinnova for facilitating cell therapy
MAGic BioProcessing receives funding from Vinnova for the IndiCell project, a precision medicine centre. IndiCell aims to establish workflows that facilitate iPSC-based cell therapies for diseases such as Parkinson’s, age-related macular degeneration and more. The centre is coordinated by Lund University and includes KI, KTH, Region Skåne, AcouSort, BioLamina, MAGic BioProcessing and will run over 5 years. The innovation centre will generate revenues of SEK 1.75 million for MAGic BioProcessing.
